Latest filing published 08 May 2026 for HLB바이오스텝. Read the official filing
No signal scores available.
Not enough history yet: 0 closed purchases, at least 2 are needed.
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
황순석, listed as chief executive, appears in our data through filings on HLB바이오스텝 shares, published by DART (FSS). We count 2 filings; the first trade dates from 6 March 2026 and the latest from 8 May 2026.
Both buying and selling appear: 1 purchase, against 1 sale. The amount is not disclosed for 2 filings. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
On 8 May 2026 came the latest disclosure, an open-market sale in HLB바이오스텝. The most recent open-market purchase was published on 6 March 2026, 226 days ago. Source: insider filings from DART (FSS). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.